Depressive symptoms and mortality-findings from Helsinki birth cohort study
Eriksson, Mia D.; Eriksson, Johan G.; Korhonen, Päivi; Koponen, Hannu; Salonen, Minna K.; Mikkola, Tuija M.; Kajantie, Eero; Wasenius, Niko S.; von Bonsdorff, Mikaela; Kautiainen, Hannu; Laine, Merja K. (2023-01-19)
Eriksson, MD, Eriksson, JG, Korhonen, P, et al. Depressive symptoms and mortality-findings from Helsinki birth cohort study. Acta Psychiatr Scand. 2023; 147( 2): 175- 185. doi:10.1111/acps.13512
N/A
https://rightsstatements.org/vocab/InC/1.0/
https://urn.fi/URN:NBN:fi-fe2023021627512
Tiivistelmä
Abstract
Background: Individuals with depression and depressive symptoms have a higher mortality rate than non-depressed individuals. The increased comorbidity and mortality associated with depression has remained largely unexplained. The underlying pathophysiological differences between depressive subtypes, melancholic and non-melancholic, may provide some explanation to this phenomenon.
Methods: One thousand nine hundred and ninety five participants (mean age 61 years) from the Helsinki Birth Cohort Study were recruited for this prospective study and followed up for a mean of 14.1 years. Information regarding medical history, lifestyle, and biochemical parameters were obtained. Depressive symptoms were assessed using the Beck Depression Inventory. Standardized mortality ratios were calculated.
Results: Participants were followed up for a total of 28,044 person-years. The melancholic depressive group had an increased adjusted risk of mortality [HR 1.49 (95% CI: 1.02–2.20)] when compared to the non-depressive group. Comparing mortality to the whole population of Finland using standardized mortality ratios (SMR) both the non-melancholic [1.11 (95% CI: 0.85–1.44)] and melancholic depressive [1.26 (95% CI: 0.87–1.81)] groups had higher mortality than the non-depressive group [0.82 (95% CI: 0.73–0.93)].
Conclusions: Melancholic depressive symptoms are most strongly related to a higher mortality risk.
Kokoelmat
- Avoin saatavuus [34237]